About
Our Organisation

SANTHE is a Pan-African network of multidisciplinary experts collaborating – through pioneering basic, clinical, and translational research - to empower African scientists in the fight against HIV/AIDS and TB, associated morbidities, and emerging diseases like COVID-19.

Learn More
Our Scientists
Fellows

Researchers/Supervisors
Support Teams

SANTHE is a productive African-led scientific consortium which has a strong research and governance infrastructure in support of all partner institutions’ pursuit of intellectual and financial independence.

Learn More
Stories of Change View All

SANTHE Post-doctoral Alumnus leads expansion into Francophon...
Read More
Our Science
News & Opportunities
Resources

Search
Login
Pambazuko

Username or E-mail

Password

Only fill in if you are not human

Forgot your password?

About
About
- Our Organisation
- Our Scientists
  - Fellows
  - Researchers/Supervisors
- Support Teams
- Stories of Change
Our Science
Our Science
- Projects
- Publications
News & Opportunities
News & Opportunities
- News
- Events
- Funding
Resources
Resources
Login Pambazuko

Home Publications Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening

Publications

N

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening

Front. Pharmacol.

View Publication

Share on social
Facebook
Twitter
LinkedIn

Authors

Divsalar, D.N., Simoben, C.V., Schonhofer, C., Richard, K., Sippl, W., Ntie-Kang, F., Tietjen, I.

About
Contact
Sitemap

SANTHE is an Africa Health Research Institute (AHRI) flagship programme funded by the Science for Africa Foundation through the DELTAS Africa programme; the Bill & Melinda Gates Foundation; Gilead Sciences Inc.; and the Ragon Institute of Mass General, MIT, and Harvard.

Copyright 2016 by SANTHE. All Rights Reserved.

Privacy
Terms and Conditions
Cookie Preference